The Government of the United States of America as represented by the Secretary of the Dep. of H.H.S.;Merck Sharp & Dohme Corp.
发明人:
Daniel J. Cua,Robert A. Kastelein,Van T. Tsai,Rachel Caspi,Phyllis Silver,Dror Luger
申请号：
US13960441
公开号：
US20130323251A1
申请日:
2013.08.06
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.
